Applications of NMR in drug discovery

Current Opinion in Chemical Biology

Volumn 5, Issue 3, 2001, Pages 285-291

  Diercks, Tammo ^a   Coles, Murray ^a   Kessler, Horst ^b  

^a Novaspin Biotech GmbH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND;

ANALYTIC METHOD; DRUG INDUSTRY; DRUG RESEARCH; LIGAND BINDING; MOLECULAR INTERACTION; NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SCREENING;

EID: 0035358813     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(00)00204-0     Document Type: Review

References (61)

1. NMR screening in drug discovery
2. NMR techniques for characterization of ligand binding: Utility for lead generation and optimization in drug discovery
3. NMR spectroscopy in structure-based drug design
4. Applications of NMR in drug discovery
5. NMR spectroscopy as a tool for structure-based drug design
6. NMR tools for biotechnology
7. Automation of NMR measurements and data evaluation for systematically screening interactions of small molecules with target proteins
8. Small volume flow probe for automated direct-injection NMR analysis: Design and performance
9. Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution
10. Transverse relaxation optimised spin-state selective NMR experiments for measurement of residual dipolar couplings
11. New techniques in structural NMR - Anisotropic interactions
12. Alignment of biological macromolecules in novel nonionic liquid crystalline media for NMR experiments
13. Direct observation of hydrogen bonds in proteins by interresidue h3JNC' scalar couplings
14. New developments in isotope labeling strategies for protein solution NMR spectroscopy
15. a) from solution NMR data
16. Diffusion ordered nuclear magnetic resonance spectroscopy: Principles and applications
17. Affinity NMR
18. Binding of ethidium to DNA measured using a 2D diffusion-modulated gradient COSY NMR experiment
19. Diffusion edited NMR: Screening compound mixtures by affinity NMR to detect binding ligands to vancomycin
20. NOE pumping: A novel NMR technique for identification of compounds with binding affinity to macromolecules
21. NOE pumping. 2. A high-throughput method to determine compounds with binding affinity to macromolecules by NMR
22. Covalent or trapped? PFG diffusion MAS NMR for combinatorial chemistry
23. One-dimensional relaxation- and diffusion-edited NMR methods for screening compounds that bind to macromolecules
24. The SHAPES strategy: An NMR-based approach for lead generation in drug discovery
25. 13C T1 relaxation at natural isotopic abundance: A practical method for determining site-specific changes in ligand flexibility upon binding to a macromolecule
26. Recent developments in transferred NOE methods
27. + bound to lactate dehydrogenase determined by nuclear magnetic resonance with suppression of spin-diffusion
28. Mapping the binding of synthetic disaccharides representing epitopes of chlamydial lipopolysaccharide to antibodies with NMR
29. Screening mixtures for biological activity by NMR
30. Mapping the active site of angiotensin-converting enzyme by transferred NOE spectroscopy
31. Bioaffinity NMR spectroscopy: Identification of an E-selectin antagonist in a substance mixture by transfer NOE
32. Application of NMR based binding assays to identify key hydroxy groups for intermolecular recognition
33. Improving bioaffinity NMR spectra by means of zero-quantum dephasing
34. Application of 3D-TOCSY-tr-NOESY for the assignment of bioactive ligands from mixtures
35. Characterization of ligand binding by saturation transfer difference NMR spectroscopy
36. Group epitope mapping (GEM) to identify segments of a ligand in direct contact with a protein: STD NMR as a tool to characterize binding to Ricinus communis agglutinin
37. Detecting binding affinity to immobilized receptor proteins in compound libraries by HR-MAS STD NMR
38. Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water
39. Second-site NMR screening with a spin-labelled first ligand
40. The inter-ligand Overhause effect: A powerful new NMR approach for mapping structural relationships of macromolecular ligands
41. Spin label enhanced NMR screening
42. Measurement of dipolar couplings in a transducin peptide fragment weakly bound to oriented photo-activated rhodopsin
43. Localization of the binding site for the oligosaccharide moiety of GB3 on verotoxin 1 using NMR residual dipolar coupling measurements
44. High-throughput nuclear magnetic resonance-based screening
45. An NMR analysis of ubiquitin recognition by yeast ubiquitin hydrolase: Evidence for novel substrate recognition by a cysteine protease
46. NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP
47. Discovery of potent nonpeptide inhibitors of stromelysin using SAR by NMR
48. Discovering high-affinity ligands for proteins: SAR by NMR
49. NMR-based discovery of phosphotyrosine mimetics that bind to the Lck SH2 domain
50. Novel inhibitors of Erm methyltransferases from NMR and parallel synthesis
51. Identification of novel inhibitors of urokinase via NMR-based screening
52. Design of adenosine kinase inhibitors from the NMR-based screening of fragments
53. NMR-based screening of proteins containing 13C-labeled methyl groups
54. The use of differential chemical shifts for determining the binding site location and orientation of protein-bound ligands
55. Use of organic solvents and small molecules for locating binding sites on proteins in solution
56. Mapping the interface of protein-nucleic acid complexes using cross-saturation
57. A novel NMR method for determining the interfaces of large protein-protein complexes
58. The properties of known drugs. 1. Molecular frameworks
59. Properties of known drugs. 2. Side chains
60. Privileged molecules for protein binding identified from NMR-based screening
61. Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein